Duties: As a Cardiovascular and Metabolism (CVM) Therapeutic Area Biomarker Lead (TABL) you will lead the CVM disease area biomarker matrix team and be responsible for the development and implementation of “fit for purpose” biomarker strategies and providing an effective interface for transitioning projects from early to later stage clinical development. You will be a core member of CVM clinical project teams, engaged in Translational Data Science teams, and provide therapeutic area line function review for clinical protocols. As a TABL you will lead efforts to identify, develop, and drive disease, mechanistic and compound biology that serves the clinical and precision medicine approaches for the multi-indication CVM portfolio that focuses on heart failure, atherosclerosis, obesity and atrial fibrillation indications
Requirements: MD, MD/PhD, or PhD degree required, plus additional PhD/postdoc or equivalent level research; Deep understanding of cardiovascular and metabolic disease epidemiology that can be applied to questions of diagnosis, biomarker development and treatment monitoring strongly preferred; Scientific excellence supported by recognized high quality publications; clinical and/or biological expertise in cardiovascular and metabolic diseases (Board certified or similar level preferred); Experience performing similar role within a pharmaceutical/biotechnology research company, clinical research organization or academic medical center